- Home
- LNZA vs TLPH Comparison
LNZA vs TLPH Comparison
Compare LNZA & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNZA | TLPH |
|---|---|---|
| Founded | 2005 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.5M | 70.3M |
| IPO Year | 2021 | 2010 |
Fundamental Metrics
Financial Performance| Metric | LNZA | TLPH |
|---|---|---|
| Price | $6.07 | $1.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.13 |
| AVG Volume (30 Days) | 46.8K | ★ 148.3K |
| Earning Date | 11-18-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 17.00 | N/A |
| Revenue | ★ $55,845,000.00 | $2,151,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.36 | ★ N/A |
| Revenue Growth | ★ 12.61 | N/A |
| 52 Week Low | $5.02 | $0.69 |
| 52 Week High | $44.00 | $1.57 |
Technical Indicators
Market Signals| Indicator | LNZA | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 52.33 | 35.90 |
| Support Level | $5.53 | $0.76 |
| Resistance Level | $6.45 | $1.13 |
| Average True Range (ATR) | 0.28 | 0.04 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 64.37 | 25.00 |
Price Performance
Historical ComparisonAbout LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a provider of carbon management and conversion technologies, focused on transforming waste materials into high-value fuels, chemicals, and critical industrial inputs. Its mission is to drive energy resilience, industrial competitiveness, and supply chain security by leveraging scalable biotechnology solutions to maximize the value of domestic resources. The company operates in North America, Europe, the Middle East, Africa (EMEA), Asia, and Australia, with the majority of its revenue generated from North America.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.